BDBM416474 N-((5-(ethylsulfonyl)pyridin-2-yl)methyl)-1-isobutyl-2-(((1r,4r)-4-(trifluoromethyl)cyclohexyl)methyl)-1H-benzo[d]imidazole-5-carboxamideN-((5-(ethylsulfonyl)pyridin-2-yl)methyl)-1-isobutyl-2-(((1s,4s)-4-(trifluoromethyl)cyclohexyl)methyl)-1H-benzo[d]imidazole-5-carboxamide::US10301261, Compound BE-26.2

SMILES CCC(C)n1c(C[C@H]2CC[C@@H](C(F)(F)F)CC2)nc2cc(C(=O)NCc3ccc(S(=O)(=O)CC)nc3)ccc21

InChI Key InChIKey=DXWPUDMSKYOOFF-UHFFFAOYSA-N

Data  1 KI  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 416474   

TargetNuclear receptor ROR-gamma(Human)
Vitae Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 416474BDBM416474(US10301261, Compound BE-26.2 | N-((5-(ethylsulfony...)
Affinity DataKi: <100nMAssay Description:Compounds described herein were tested for ability to bind to RORγ in a cell-free competition assay with commercially available radio-ligand (RL...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details
US Patent